Elizabeth Sconce
Dr Hilary Wynne
Professor Farhad Kamali
| Factors Affecting Anticoagulation Response to Warfarin | 2008 |
|
Elizabeth Sconce
Dr Peter Avery
Dr Hilary Wynne
Professor Farhad Kamali
| Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism influences the anticoagulation response subsequent to vitamin K intake: A pilot study | 2008 |
|
Dr Ellen Hatch
Elizabeth Sconce
Dr Barry King
Dr Hilary Wynne
Professor Ann Daly
et al. | Polymorphisms in genes associated with the vitamin K epoxide reductase complex do not affect warfarin dose requirement | 2007 |
|
Elizabeth Sconce
Dr Peter Avery
Dr Hilary Wynne
Professor Farhad Kamali
| Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin | 2007 |
|
Elizabeth Sconce
Dr Hilary Wynne
Professor Farhad Kamali
| Vitamin K supplementation during oral anticoagulation: No real cause for concern [2] | 2007 |
|
Dr Ellen Hatch
Elizabeth Sconce
Emerita Professor Ann Daly
Professor Farhad Kamali
| A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1) gene | 2006 |
|
Elizabeth Sconce
Emerita Professor Ann Daly
Dr Tayyaba Khan
Dr Hilary Wynne
Professor Farhad Kamali
et al. | APOE genotype makes a small contribution to warfarin dose requirements | 2006 |
|
Elizabeth Sconce
Dr Tayyaba Khan
Professor Ann Daly
Dr Hilary Wynne
Professor Farhad Kamali
et al. | Apolipoprotein E polymorphisms do not make a clinically significant contribution to warfarin dose requirements | 2006 |
|
Elizabeth Sconce
Professor Farhad Kamali
| Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: The need for a more tailored dosing regimen | 2006 |
|
Elizabeth Sconce
Dr Tayyaba Khan
Emerita Professor Ann Daly
Dr Hilary Wynne
Professor Farhad Kamali
et al. | The impact of simvastatin on warfarin disposition and dose requirements | 2006 |
|
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Dr Patrick Kesteven
Dr Peter Avery
et al. | [abstract] Pfizer poster communication prize - The influence of patient age, CYP2C9 genotype and height on warfarin dose requirements | 2005 |
|
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Professor Farhad Kamali
| Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation | 2005 |
|
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Professor Farhad Kamali
| Patients with unstable control have a poorer dietary intake of vitamin K compared with patients with stable control of anticoagulation | 2005 |
|
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Dr Peter Avery
Dr Barry King
et al. | The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen | 2005 |
|
